A prognostic marker for the prediction of the five-year progression free survival of patients with colorectal carcinomas, based on expression profiles of biological samples

摘要

The invention relates to the use of gene expression profiles for predicting the five-year progression or relapse-free survival of patients whose colorectal carcinoma in the UICC Stadium I or II is removed.